IP Group

Lumai specializes in the development of fully optical computing systems, integrating photonics and machine learning to create faster and more energy-efficient computing solutions. By leveraging optical technologies, Lumai aims to provide significant advantages over traditional electronic systems, including reduced energy consumption and enhanced processing speeds. The company's innovations are designed to support the advancement of next-generation artificial intelligence, enabling consumers and businesses to benefit from quicker and more sustainable computing capabilities.

Diffblue Limited, based in Oxford, United Kingdom, specializes in artificial intelligence software that automates various coding tasks, primarily focusing on enhancing Java development through automated testing solutions. Founded in 2016 as a spin-out from the AI research group at Oxford, Diffblue's technology autonomously generates unit tests, which helps developers save time and ensure software robustness. The software not only creates fully formed tests guaranteed to compile and run, but also identifies and fixes bugs, refactors code, and maintains regression tests. By providing insights into test coverage, code testability, and complexity, Diffblue aims to transform the software development process, making it more efficient and less error-prone.

Alimetry is a health technology startup located in Auckland, New Zealand, focused on creating innovative solutions for diagnosing gastrointestinal disorders. The company has developed a symptom-tracking and real-time gastric mapping monitoring device that investigates gastric function. This device detects the underlying motility of the stomach, helping to identify the causes of common symptoms such as abdominal pain, indigestion, nausea, and vomiting. By enabling patients to better understand their gastrointestinal health, Alimetry aims to enhance the overall care and management of GI disorders.

Alesi Surgical Ltd. specializes in the development and commercialization of laparoscopic surgical smoke handling systems aimed at enhancing the safety and outcomes of surgical procedures. Founded in 2009 and based in Cardiff, United Kingdom, the company emerged as a spin-out from the Welsh Institute for Minimal Access Therapy, benefiting from direct access to experienced surgeons and surgical trainers. Alesi Surgical's innovative products are designed to be portable and applicable in both laparoscopic and robot-assisted surgeries. Utilizing electrostatic precipitation technology, these tools effectively eliminate surgical smoke, ensuring a clear visual field during procedures. Alesi Surgical distributes its products to hospitals across Europe, the Middle East, New Zealand, and Australia.

Microbiotica Limited is a biotechnology company based in Cambridge, United Kingdom, founded in 2016. The company specializes in the development of human microbiome-based therapeutics and biomarkers. Its platform is designed to identify gut bacteria associated with specific phenotypes, offering a high level of precision. This capability allows researchers to determine phenotypes before conducting tests on candidate bacteria using advanced in vitro and in vivo models. By focusing on the science of the microbiome, Microbiotica aims to advance the understanding and application of live bacterial therapeutics in clinical settings.

MISSION Therapeutics is a biotechnology company specializing in developing drugs that target the cellular process of deubiquitylation for the treatment of cancer and other diseases. Their focus is on developing small molecule drugs that selectively inhibit specific deubiquitylating enzymes (DUBs), which play crucial roles in regulating protein degradation and cellular processes. These drugs aim to intervene in disease mechanisms where DUB dysregulation is implicated, offering potential therapeutic benefits.

Enterprise Therapeutics Ltd. is a drug discovery company based in Brighton, United Kingdom, founded in 2014. It focuses on the research and development of innovative therapies for respiratory diseases, specifically targeting chronic obstructive pulmonary disease (COPD), cystic fibrosis, and asthma. The company aims to create disease-modifying therapies that address the underlying mechanisms of mucus congestion in the lungs, which can lead to breathing difficulties and increased susceptibility to lung infections. By developing these novel treatments, Enterprise Therapeutics seeks to enhance the quality of life for patients suffering from these chronic respiratory conditions.

Oxford Quantum Circuits specializes in quantum computing technology that aims to address significant global challenges, such as climate change and drug discovery. The company has developed a fully functional quantum computer that integrates control systems, hardware, and software, enabling customers to streamline operations and explore innovative solutions. Their unique superconducting circuits are designed to maintain high qubit quality and control, which is essential for achieving commercially viable processing power. By leveraging this advanced technology, Oxford Quantum Circuits supports a range of applications, from pioneering new battery technologies to facilitating life-changing discoveries in medicine.

Crescendo Biologics Limited is a Cambridge-based company focused on developing innovative therapies for oncology and dermatology, particularly through small molecules and monoclonal antibodies. The company specializes in multi-specific immune-oncology modulators and Humabody Drug Conjugates, leveraging a proprietary transgenic mouse platform that facilitates the in vivo maturation of human VH domains. This technology allows Crescendo to optimize the affinity and biophysical properties of its Humabodies, which are small antibody fragments retaining essential binding capabilities. By addressing challenges in generating high-affinity, soluble human VH antibody fragments, Crescendo aims to develop potent, multi-functional therapeutics. The company engages in both in-house product development and partnerships with other organizations to expand its impact in the field of antibody therapeutics. Established in 2007, Crescendo Biologics was originally named Translocus Limited before rebranding in 2009.

OxCCU specializes in renewable energy technology aimed at fostering a circular economy for fuels, chemicals, and plastics. The company’s innovative approach utilizes carbon dioxide extracted from the atmosphere, hydrogen sourced from water, and renewable electricity to produce sustainable fuels, chemicals, and biodegradable plastics. By doing so, OxCCU enables clients to adopt more environmentally friendly products, contributing to a more sustainable future.

AccelerComm Ltd specializes in providing Forward Error Correction (FEC) solutions for various communication markets, including mobile handsets, base stations, and satellite standards. Founded in 2016 and based in Southampton, United Kingdom, the company focuses on enhancing the performance of next-generation wireless communications, addressing challenges such as noise, interference, and weak signal strength. Its product offerings include a range of encoding and decoding technologies, such as Polar, Turbo, and LDPC (Low-Density Parity-Check) decoders, specifically designed to meet 3GPP compliance. By delivering innovative semiconductor IP-core products, AccelerComm aims to facilitate optimal performance in digital communications while supporting the evolving needs of the industry.

Deep Render Ltd. is a London-based AI start-up that originated from the Department of Computing at Imperial College London. The company specializes in developing advanced media compression algorithms using proprietary and patented technology grounded in machine learning research. Its innovative approach focuses on deep learning, density estimation, and unsupervised learning, resulting in state-of-the-art Biological Image Compression that offers at least a 50% efficiency gain over existing standards. Deep Render's technology is notable for being the first AI-based codec capable of real-time video playback, allowing for significant market expansion and cost reduction for users.

Intrinsic Semiconductor Technologies focuses on developing silicon-oxide-based resistive random-access memory (RRAM) technologies. The company specializes in creating memristive devices that serve as next-generation non-volatile memory solutions. Their technology is fully air stable and compatible with complementary metal-oxide-semiconductor (CMOS) processes, allowing for integration into standard devices even at advanced process nodes. This capability enables the production of low-power, cost-effective semiconductors that can operate under higher power ratings, including elevated frequencies and temperatures. Intrinsic's offerings can be configured for various applications, such as multilevel memory, hardware acceleration for machine learning, and neuromorphic computing, positioning the company at the forefront of innovation in the semiconductor industry.

Quantum Motion Technologies is focused on developing universal quantum computers utilizing silicon-based, CMOS-compatible processes. The company aims to address key challenges in quantum computing, such as fault tolerance and qubit redundancy, by creating scalable architectural technologies. By leveraging complementary metal-oxide semiconductor processing, Quantum Motion strives to achieve greater qubit density, enabling the construction of large-scale quantum systems. This approach not only enhances the performance of quantum computers but also assists clients in the quantum technology sector in overcoming significant errors and critical challenges in quantum information processing.

AudioScenic Limited, founded in 2017 and headquartered in Southampton, United Kingdom, specializes in developing advanced 3D audio technology that enhances the listening experience across various sectors, including cinema, gaming, production, automotive, and public spaces. The company's innovative approach utilizes small arrays of speakers combined with head-tracking technology to deliver controlled sound beams directly to the listener's ears, creating a virtual headphone effect without the need for traditional headphones or bulky speaker setups. This technology allows users to experience immersive audio that accurately simulates sound positioned in three-dimensional space, surpassing the quality of conventional loudspeaker systems. AudioScenic's solutions are adaptable for diverse applications and are supported by their proprietary Virtua 3D Engine, which is designed for efficient signal processing across various platforms. The company collaborates closely with partners and customers to provide tailored acoustic designs, ensuring an authentic and natural audio experience for all users.

STORM Therapeutics Limited is a biotechnology company based in Cambridge, United Kingdom, focused on discovering and developing small molecule drugs that target RNA-modifying enzymes for cancer treatment and other immune diseases. Founded in 2015 and formerly known as Iceni Therapeutics Limited, the company utilizes a drug discovery and RNA analytics platform to identify novel targets and first-in-class drug candidates. By modulating RNA-modifying enzymes, STORM Therapeutics aims to address a range of diseases, including oncology, inflammation, viral infections, and central nervous system disorders. The company's innovative approach seeks to provide physicians with effective therapies targeting RNA epigenetic mechanisms.

Pulmocide Ltd is a London-based company established in 2007 that specializes in developing inhaled medicines aimed at treating serious viral and fungal infections of the respiratory tract. The company focuses on creating a new generation of antifungal drugs tailored for inhalation, which enhances the delivery of medication directly to the lungs while reducing systemic exposure. This targeted approach is designed to improve efficacy against respiratory aspergillosis and minimize systemic toxicities, thereby offering safe and effective treatment options for patients with acute and chronic respiratory diseases.

Diffblue Limited, based in Oxford, United Kingdom, specializes in artificial intelligence software that automates various coding tasks, primarily focusing on enhancing Java development through automated testing solutions. Founded in 2016 as a spin-out from the AI research group at Oxford, Diffblue's technology autonomously generates unit tests, which helps developers save time and ensure software robustness. The software not only creates fully formed tests guaranteed to compile and run, but also identifies and fixes bugs, refactors code, and maintains regression tests. By providing insights into test coverage, code testability, and complexity, Diffblue aims to transform the software development process, making it more efficient and less error-prone.

Kale United AB, founded in 2018 and headquartered in Stockholm, Sweden, specializes in providing advisory services to plant-based member companies. These services encompass marketing, public relations, sales and distribution, financing, community engagement, accounting, and human resources. The company focuses on supporting vegan startups and aims to foster growth within the plant-based food sector across the Nordic region.

Innervace is a regenerative therapy company based in Philadelphia, Pennsylvania, focused on developing implantable tissue-engineered brain pathways to address neurodegenerative disorders. The company specializes in creating anatomically inspired living scaffolds designed for brain pathway reconstruction. Its lead clinical product is a tissue-engineered nigrostriatal pathway, which aims to replicate the lost pathway in patients with Parkinson's disease. By concentrating on the reconstruction of brain pathways rather than merely alleviating symptoms temporarily, Innervace offers innovative solutions that aim to improve the quality of life for individuals affected by these conditions. Established in 2018, the company is dedicated to advancing its products from development to commercialization.

AMSL Aero is a developer of electric vertical take-off and landing aircraft, focusing on innovative solutions for future mobility. Their flagship aircraft, Vertiia, can cruise at speeds of 300 km/h and has a range of 250 km on electric batteries. This aircraft aims to transform transportation in aeromedical, emergency services, and passenger markets by providing a safe, fast, and environmentally friendly alternative to ground travel. With the ability to bypass traffic congestion, Vertiia can operate from various locations equipped with landing pads, offering a new mode of transport that enhances accessibility and efficiency.

Somalytics specializes in the development of miniature sensors aimed at enhancing eye tracking, human-machine interfaces, wearables, and industrial safety applications. Founded in 2021 and based in Seattle, Washington, the company has introduced the world's first paper-composite capacitive sensor, which is characterized by its thin profile, low power consumption, and potential disposability. Utilizing innovative carbon nanotube technology, Somalytics' sensors offer improved sensitivity and aim to replace traditional cameras and sensors in various applications, ultimately enhancing the user experience through superior technology.

Nexeon Limited is a developer and manufacturer of advanced silicon-based anode materials for rechargeable lithium-ion batteries. Founded in 2006 and headquartered in Abingdon, United Kingdom, with an additional office in Yokohama, Japan, the company focuses on creating innovative battery materials that enhance energy density and capacity. These improvements allow for the production of lighter, more powerful batteries that can support a variety of applications, including consumer electronics, electric vehicles, sustainable energy, aerospace, medical, and defense industries. By enabling longer battery life and faster charging times, Nexeon's technology plays a crucial role in advancing sustainable energy solutions and supporting the transition to a net-zero environment. The company boasts a skilled technical team with diverse expertise to drive its research and development efforts.

Hysata is focused on developing an innovative hydrogen electrolyzer system designed to facilitate the transition from fossil fuels to green hydrogen. The company's technology aims to significantly reduce the cost of green hydrogen production to below $2 per kilogram, thereby promoting a faster shift towards net-zero emissions. Based on pioneering research from Professor Gerry Swiegers at the University of Wollongong's ARC Centre of Excellence for Electromaterials Science, Hysata's electrolyzers efficiently utilize electricity to split water into hydrogen and oxygen through electrolysis. This advancement not only addresses the growing energy demand but also supports companies in their efforts to achieve sustainability goals.

Oxford Science Enterprises is a venture firm based in Oxford, United Kingdom, established in 2015 in partnership with the University of Oxford. The firm focuses on building and investing in companies that develop fundamental technologies aimed at addressing significant global challenges. Its investment areas include life sciences, healthcare, artificial intelligence, software, and deep tech, targeting issues such as nuclear fusion, quantum computing, and the development of treatments for infectious diseases. By leveraging its extensive experience and a robust network of investors, entrepreneurs, and sector experts, Oxford Science Enterprises aims to foster a world-class technology ecosystem and support the growth of innovative science-based businesses.

Abliva AB is a Swedish pharmaceutical company focused on the research and development of treatments for primary mitochondrial diseases, which are rare and severe conditions caused by dysfunctional mitochondria. The company's pipeline includes KL1333, currently in phase I clinical trials, and NV354, an energy replacement therapy that is preparing for clinical trials. KL1333 is noted for its role as a regulator of NAD+ and NADH, and has received orphan drug designation in both Europe and the United States. Additionally, Abliva is developing NeuroSTAT for the treatment of traumatic brain injury. Established in 2000 and headquartered in Lund, Sweden, Abliva has formed collaborations with various institutions, enhancing its research capabilities and clinical development efforts.

MoA Technology Ltd. is a plant genetics company based in Leeds, United Kingdom, that was incorporated in 2017. It was spun out from the University of Oxford and focuses on developing innovative agricultural technologies aimed at enabling farmers to produce healthy food through sustainable crop systems. The company leverages research led by Professor Liam Dolan to discover new methods that enhance agricultural productivity while promoting sustainability.

Ankere is striving to develop transformative therapies based on excellent science that will enable people to live long and healthy lives.

SLAMcore Limited specializes in developing simultaneous localization and mapping (SLAM) solutions tailored for various applications, including robotics, augmented reality, and autonomous vehicles. Founded in 2016 and based in London, the company has created advanced SLAM software that enables robots and devices equipped with outward-facing sensors to understand and navigate unfamiliar environments. Their technology includes Visual SLAM, sensor fusion, and Event Camera SLAM, which collectively enhance real-time spatial understanding. By fusing data from multiple sensors, SLAMcore's platform utilizes computer vision and machine learning to improve the efficiency and accuracy of robotic systems. The company offers a software development kit (SDK) that facilitates rapid prototyping for commercial products, allowing for customization on standard computing platforms. Through partnerships with original equipment manufacturers, SLAMcore aims to integrate its core technology into everyday products, making spatial intelligence more accessible and practical in various industries.

GripAble Ltd. designs and develops digital therapy devices aimed at improving rehabilitation for individuals with movement impairments such as stroke, arthritis, cerebral palsy, and trauma. Founded in 2017 and based in London, the company offers a portable, wireless handgrip device that connects to a mobile application. This application allows users to engage with therapy games while providing assessment and training for hand and arm functions. GripAble's innovative approach focuses on making therapy more accessible and engaging for patients, enabling them to practice essential daily tasks in a fun and motivating way. By combining hardware and software, GripAble addresses the needs of over 500 million people worldwide who face challenges with arm mobility, facilitating self-training both in clinical settings and at home.

Kynos Therapeutics is a biotechnology company focused on developing KMO inhibitors to address unmet medical needs in inflammation, immunity, and metabolism. The company aims to block the action of the enzyme KMO, which plays a crucial role in regulating systemic inflammation and is implicated in various medical conditions. By providing new therapies that target this key enzyme, Kynos Therapeutics seeks to offer innovative treatments for conditions where there is a significant demand for effective medicines.

Aptatek Biosciences Inc. is a company based in Princeton, New Jersey, focused on developing portable disease management devices specifically for individuals with Phenylketonuria (PKU). Their innovative products utilize sensor technology to monitor phenylalanine levels in real-time, allowing for immediate analysis and reporting of blood samples. The core technology leverages DNA aptamer sequences to detect small-molecule biomarkers, facilitating the identification of various markers that are typically analyzed in centralized laboratories. By enabling real-time blood tests and supporting immediate dietary adjustments, Aptatek's devices aim to enhance patient compliance and overall quality of life for those managing PKU.

Vytal provides software-enabled reusable packaging solutions aimed at reducing single-use packaging waste in the food and beverage industry. The company offers a reusable container system and accompanying container management software designed to support sustainable takeaway and delivery services. Its services cater to a diverse clientele, including restaurants, supermarkets, caterers, canteens, and event organizers. Vytal's platform allows businesses and individual consumers to access high-quality reusable packaging at a pay-per-use price that is more economical than disposable options. Users can conveniently borrow containers for free and return them at various locations or through delivery services, thereby facilitating a circular approach to packaging and contributing to the reduction of plastic waste.

Alimetry is a health technology startup located in Auckland, New Zealand, focused on creating innovative solutions for diagnosing gastrointestinal disorders. The company has developed a symptom-tracking and real-time gastric mapping monitoring device that investigates gastric function. This device detects the underlying motility of the stomach, helping to identify the causes of common symptoms such as abdominal pain, indigestion, nausea, and vomiting. By enabling patients to better understand their gastrointestinal health, Alimetry aims to enhance the overall care and management of GI disorders.

Helio Display Materials specializes in developing innovative perovskite-based materials designed to enhance the performance and efficiency of display technologies. By utilizing metal halide perovskites, the company creates materials that enable displays to produce richer and more vibrant colors while consuming significantly less power. Helio's mission focuses on improving the overall visual experience, making displays brighter and more colorful. The company is committed to advancing research and development in this field by collaborating with scientific and industry experts, ensuring a strong intellectual property foundation rooted in scientific principles. Through its groundbreaking materials, Helio aims to revolutionize the display industry, particularly for televisions and other visual technologies.

Barocal specializes in innovative cooling technology aimed at addressing low-carbon refrigeration needs. The company has developed a system that utilizes materials capable of significant thermal changes when pressure is applied or removed. This unique approach enhances energy efficiency while ensuring a zero greenhouse warming impact, particularly in the commercial food and drink refrigeration sector. By implementing Barocal's technology, clients can effectively reduce their indirect emissions of greenhouse gases, contributing to a more sustainable environment.

First Light Fusion Limited, founded in 2011 and based in Begbroke, United Kingdom, specializes in advanced implosion processes for electricity generation through inertial confinement fusion. The company originated as a spin-out from the University of Oxford and actively engages in researching and developing sustainable renewable energy solutions. It employs a team of engineers and physicists and collaborates with several academic institutions, including the University of Oxford, Warwick University, UCL, and Imperial College London. First Light Fusion focuses on harnessing fundamental physics to discover new energy sources, utilizing detailed numerical simulations and experimental validation in its research efforts.

Bramble Energy Ltd. is a London-based company that specializes in the design, development, and manufacture of printed circuit board (PCB) fuel cells, specifically proton exchange membrane fuel cells (PEMFCs). Incorporated in 2015, it leverages the capabilities of the global PCB industry to produce high-performance, cost-effective fuel cell stacks. The company's product lineup includes modular PCBFC stacks, ranging from 20 W to 5 kW, as well as custom-designed solutions. Bramble Energy serves various sectors, including stationary, portable, and automotive applications, aiming to provide gigawatts of fuel cell hardware. By utilizing innovative manufacturing methods and materials, the company enables clients to reduce energy consumption and lower their carbon footprints.

Microbiotica Limited is a biotechnology company based in Cambridge, United Kingdom, founded in 2016. The company specializes in the development of human microbiome-based therapeutics and biomarkers. Its platform is designed to identify gut bacteria associated with specific phenotypes, offering a high level of precision. This capability allows researchers to determine phenotypes before conducting tests on candidate bacteria using advanced in vitro and in vivo models. By focusing on the science of the microbiome, Microbiotica aims to advance the understanding and application of live bacterial therapeutics in clinical settings.

Diffblue Limited, based in Oxford, United Kingdom, specializes in artificial intelligence software that automates various coding tasks, primarily focusing on enhancing Java development through automated testing solutions. Founded in 2016 as a spin-out from the AI research group at Oxford, Diffblue's technology autonomously generates unit tests, which helps developers save time and ensure software robustness. The software not only creates fully formed tests guaranteed to compile and run, but also identifies and fixes bugs, refactors code, and maintains regression tests. By providing insights into test coverage, code testability, and complexity, Diffblue aims to transform the software development process, making it more efficient and less error-prone.

Lumai specializes in the development of fully optical computing systems, integrating photonics and machine learning to create faster and more energy-efficient computing solutions. By leveraging optical technologies, Lumai aims to provide significant advantages over traditional electronic systems, including reduced energy consumption and enhanced processing speeds. The company's innovations are designed to support the advancement of next-generation artificial intelligence, enabling consumers and businesses to benefit from quicker and more sustainable computing capabilities.

Canopus Networks Pty Ltd is an Australian company founded in 2018, specializing in software-defined networking and artificial intelligence technologies. The company focuses on providing solutions for internet service providers to effectively manage and isolate streaming video and gaming traffic, ensuring a consistent user experience during network congestion. Canopus develops a platform that offers encryption-proof network observability, enabling high-speed analysis of network flows. This platform is essential for telecommunications operators who need to monitor application and network performance amidst increasing data rates and encryption challenges. Canopus serves various sectors, including fixed operators, gaming, 5G mobile operators, live video streaming, business applications, security, and government entities.

Navenio Limited is a software technology company based in Oxford, United Kingdom, that specializes in location-based services for indoor environments. Founded in 2015, Navenio offers a mobile application solution that enhances indoor localization by enabling the tracking of individuals without the need for additional hardware, such as beacons or Wi-Fi. This innovative approach utilizes fingerprinting of the electromagnetic spectrum, sensor data, and indoor mapping to provide accurate location monitoring across various sectors, including retail, transportation, venues, and healthcare. Navenio's intelligent workforce solution significantly improves operational efficiency and workflow by automating processes based on real-world best practices.

Ieso Digital Health Ltd. is a provider of online, evidence-based mental health therapy, focusing on cognitive behavioral therapy (CBT) delivered through a digital platform. The company offers one-to-one therapy sessions for various mental health issues, including anxiety, depression, and phobias, as well as support for chronic physical health problems and cognitive impairments. Ieso's innovative approach combines proprietary technology with natural language processing and artificial intelligence to enhance therapy delivery through real-time monitoring and assessment. This enables therapists to provide effective care in a virtual environment, allowing patients to access support at their convenience. Serving a diverse clientele that includes health providers, private individuals, and businesses, Ieso aims to transform mental healthcare by making it more accessible and scalable. Founded in 2000 and based in Swavesey, United Kingdom, Ieso was previously known as PsychologyOnline.co.uk Limited before rebranding in 2015.

Ieso Digital Health Ltd. is a provider of online, evidence-based mental health therapy, focusing on cognitive behavioral therapy (CBT) delivered through a digital platform. The company offers one-to-one therapy sessions for various mental health issues, including anxiety, depression, and phobias, as well as support for chronic physical health problems and cognitive impairments. Ieso's innovative approach combines proprietary technology with natural language processing and artificial intelligence to enhance therapy delivery through real-time monitoring and assessment. This enables therapists to provide effective care in a virtual environment, allowing patients to access support at their convenience. Serving a diverse clientele that includes health providers, private individuals, and businesses, Ieso aims to transform mental healthcare by making it more accessible and scalable. Founded in 2000 and based in Swavesey, United Kingdom, Ieso was previously known as PsychologyOnline.co.uk Limited before rebranding in 2015.

Ultraleap Limited is a leading developer of mid-air haptic control systems and 3D hand tracking technology. Formerly known as Ultrahaptics, the company specializes in creating solutions that utilize ultrasound to generate tactile sensations, enabling users to feel three-dimensional shapes and textures without physical contact. Its flagship products include the Leap Motion Controller, which captures hand movements, and the VR Developer Mount, designed for enhancing virtual reality experiences on various headsets. The company's innovative technology is applicable across multiple industries such as extended reality, automotive, digital signage, industrial automation, consumer electronics, and location-based entertainment. Established in 2013 and headquartered in Bristol, United Kingdom, Ultraleap also has a subsidiary in Silicon Valley, United States.

Teya is a comprehensive solution tailored for small and growing businesses, offering a suite of services that facilitate efficient management and growth. The company specializes in payment processing, providing fast and secure transaction capabilities, along with cloud-native business management software. Teya's offerings include issuer payment processing and cash advance services, which assist merchants in enhancing their operations. With a commitment to supporting over 300,000 business owners, Teya enables them to effectively manage their businesses and fosters a positive experience in their entrepreneurial journey.

Hinge Health, Inc. is a digital healthcare company focused on providing innovative solutions for individuals suffering from musculoskeletal disorders. Founded in 2015 and headquartered in San Francisco, California, the company develops wearable sensors, an application platform, and support services that facilitate the treatment of chronic back and joint pain. By combining advanced technology with access to a team of physical therapists, health coaches, and orthopedic surgeons, Hinge Health aims to make high-quality care more accessible and effective. Its offerings empower users to engage in personalized digital care, enabling them to manage their pain without relying on traditional methods such as surgery or opioid medications. With additional offices in Chicago, Minneapolis, Portland, and London, Hinge Health is committed to addressing the widespread issue of musculoskeletal pain and improving the well-being of its users.

Inosi Therapeutics focuses on developing therapies to treat fibrosis, a condition characterized by tissue scarring that can lead to organ dysfunction. The company offers a unique therapeutic approach involving IRAP inhibitors, which can be used independently or in conjunction with existing treatments to enhance the management of organ damage associated with diabetes-induced kidney disease and cardiovascular disease. By targeting the underlying mechanisms of fibrosis, Inosi Therapeutics aims to provide healthcare providers with effective options to address this complication of various chronic diseases.

Quantum Dice is an award-winning spin-out from the University of Oxford specializing in quantum technology. The company develops quantum random number generators (QRNGs) that produce unbiased, true random numbers essential for modern communication technologies. These devices generate cryptographically secure random numbers that enhance security across various commercial applications. Quantum Dice's self-certified QRNGs are designed to function solely from quantum processes, ensuring improved encryption systems while safeguarding against external influences. This technology aims to provide enhanced security for an increasingly connected future.

Monolith AI Limited is a London-based software company that assists engineers in enhancing the product development process through the application of machine learning and data science. Founded in 2016, Monolith AI specializes in algorithms that integrate engineering simulations with machine learning techniques to identify optimal solutions for engineering designs. The company enables organizations to leverage existing simulation and test data, allowing them to predict the behavior of new products. This approach helps businesses streamline their research and development processes by minimizing the need for extensive simulations, tests, and prototypes, ultimately leading to faster and more effective product development. Monolith AI was formerly known as UQuant Limited and rebranded in June 2018.

Arkivum specializes in long-term data management and digital preservation, catering to organizations in data-intensive and regulated markets worldwide. The company offers cloud-based software and services that ensure data remains secure, accessible, and usable over time, addressing the needs of clients who require reliable data storage solutions. Arkivum emphasizes data integrity and provides expert guidance on compliance with evolving regulatory requirements. Its vendor-neutral technology allows clients to retain ownership of their data, avoiding lock-in with any single provider. By focusing on effective data archiving and preservation, Arkivum enables organizations to maintain the value of their data while meeting complex compliance standards.

Alesi Surgical Ltd. specializes in the development and commercialization of laparoscopic surgical smoke handling systems aimed at enhancing the safety and outcomes of surgical procedures. Founded in 2009 and based in Cardiff, United Kingdom, the company emerged as a spin-out from the Welsh Institute for Minimal Access Therapy, benefiting from direct access to experienced surgeons and surgical trainers. Alesi Surgical's innovative products are designed to be portable and applicable in both laparoscopic and robot-assisted surgeries. Utilizing electrostatic precipitation technology, these tools effectively eliminate surgical smoke, ensuring a clear visual field during procedures. Alesi Surgical distributes its products to hospitals across Europe, the Middle East, New Zealand, and Australia.

MOBILion Systems, Inc. is a biotechnology company focused on advancing the detection and analysis of clinically relevant molecules that conventional instruments struggle to identify. The company has developed structures for lossless ion manipulation (SLIM), which facilitate ion mobility separations and enable researchers to detect minute traces of disease-specific biomolecules. Founded in 2015 and based in Chadds Ford, Pennsylvania, MOBILion's technology enhances the sensitivity, resolution, and throughput of analytical instruments. This innovation supports the identification of biologic therapeutics, accelerates biomarker discovery, and improves the accuracy of diagnostic tests. By processing large-scale samples efficiently, MOBILion aims to contribute to better disease prediction, diagnosis, and treatment, ultimately empowering clinicians and researchers to address diseases at their core rather than merely treating symptoms.

Pulmocide Ltd is a London-based company established in 2007 that specializes in developing inhaled medicines aimed at treating serious viral and fungal infections of the respiratory tract. The company focuses on creating a new generation of antifungal drugs tailored for inhalation, which enhances the delivery of medication directly to the lungs while reducing systemic exposure. This targeted approach is designed to improve efficacy against respiratory aspergillosis and minimize systemic toxicities, thereby offering safe and effective treatment options for patients with acute and chronic respiratory diseases.

Oxford Nanopore Technologies is a biotechnology company specializing in nanopore-based sequencing technology for analyzing DNA, RNA, proteins, and small molecules. Its diverse product line includes the portable MinION device, the benchtop PromethION, the GridION system, and Flongle, which caters to on-demand sequencing needs. The technology enables real-time data streaming and is applicable across various fields such as human genomics, cancer research, microbiology, plant science, and environmental studies. Additionally, Oxford Nanopore's products support rapid and accessible molecular analysis, making them suitable for both laboratory and field use. The company's innovations are backed by a robust patent portfolio and are utilized in over 80 countries, addressing needs in healthcare, agriculture, and education. Founded in 2005 and headquartered in Oxford, United Kingdom, Oxford Nanopore also maintains offices in several other countries, enhancing its global reach in advancing genomic research and applications.

Intrinsic Semiconductor Technologies focuses on developing silicon-oxide-based resistive random-access memory (RRAM) technologies. The company specializes in creating memristive devices that serve as next-generation non-volatile memory solutions. Their technology is fully air stable and compatible with complementary metal-oxide-semiconductor (CMOS) processes, allowing for integration into standard devices even at advanced process nodes. This capability enables the production of low-power, cost-effective semiconductors that can operate under higher power ratings, including elevated frequencies and temperatures. Intrinsic's offerings can be configured for various applications, such as multilevel memory, hardware acceleration for machine learning, and neuromorphic computing, positioning the company at the forefront of innovation in the semiconductor industry.

Carisma Therapeutics is a clinical-stage biotechnology company dedicated to developing innovative immunotherapies for cancer and other serious diseases through its proprietary chimeric antigen receptor macrophage technology. The company focuses on engineering macrophages and monocytes, which are specialized white blood cells, to enhance their ability to infiltrate solid tumors and deliver potent cellular immunotherapy. By leveraging advanced cell engineering techniques, Carisma aims to provide effective treatments that enable patients with solid tumors to benefit from targeted and robust cancer therapies.

Oxular Limited is a clinical-stage company based in Oxford, United Kingdom, focused on developing innovative retinal treatments to address various retinal diseases. Founded in 2014, the company specializes in tissue-specific drug delivery technology aimed at improving the effectiveness of treatments for conditions such as age-related macular degeneration, diabetic macular edema, retinal vein occlusion, and cystoid macular edema. By targeting specific areas within the eye, Oxular seeks to enhance therapeutic outcomes while minimizing side effects and reducing the frequency of treatments, thereby offering patients effective and life-changing solutions for their unmet medical needs.

C-Capture Limited, founded in 2008 and based in Leeds, United Kingdom, specializes in the development and design of solvent systems for the removal of carbon dioxide (CO2) from gas streams. The company utilizes its expertise in CO2-based chemistry and engineering to create absorbents for reversible CO2 capture, particularly in post-combustion processes. C-Capture focuses on providing non-toxic and economically viable carbon capture solutions for emission sources, including flue gases from power generators and hard-to-abate industries. By offering innovative technology for capturing CO2, C-Capture aims to contribute to more sustainable electricity generation and address the environmental challenges posed by greenhouse gas emissions.

Centessa Pharmaceuticals is a clinical-stage biopharmaceutical company focused on innovating the drug development process through an asset-centric research and development model. The company manages a diverse portfolio of therapeutics across several therapeutic areas, including SerpinPC for Hemophilia A and B, LB101 for solid tumors, ORX750 for Narcolepsy Type 1 and other sleep disorders, and MGX292 for pulmonary arterial hypertension. Each therapeutic program is developed by a dedicated subsidiary, leveraging a centralized infrastructure and experienced management team to ensure efficient advancement of its pipeline assets.

Carisma Therapeutics is a clinical-stage biotechnology company dedicated to developing innovative immunotherapies for cancer and other serious diseases through its proprietary chimeric antigen receptor macrophage technology. The company focuses on engineering macrophages and monocytes, which are specialized white blood cells, to enhance their ability to infiltrate solid tumors and deliver potent cellular immunotherapy. By leveraging advanced cell engineering techniques, Carisma aims to provide effective treatments that enable patients with solid tumors to benefit from targeted and robust cancer therapies.

Oxa is a developer of autonomous vehicle software that focuses on creating AI-based platforms for the operation and scaling of fleets of autonomous vehicles. The company's technology combines laser vision and radar for effective localization, allowing autonomous systems to understand their surroundings and navigate safely in complex environments. Oxa's software is designed to operate with low compute power requirements, making it accessible for various business applications. By providing solutions that enhance vehicle positioning and movement prediction, Oxa enables clients to implement and accelerate the deployment of autonomous vehicles in a range of settings.

8Power Limited specializes in the manufacturing of autonomous sensor systems tailored for various sectors, including automotive, transportation, civil engineering, industrial equipment, and utility infrastructure. The company has developed wireless sensor technology that provides real-time condition monitoring data and analytics for industrial applications. This technology enables clients to monitor the performance of their assets, such as pumps, motors, and gearboxes, across numerous remote locations. By offering a cost-effective solution, 8Power facilitates easy installation and effective machine condition monitoring, serving industries such as water and waste treatment, manufacturing, and oil and gas.

Econic Technologies Ltd. is a UK-based chemical technology company that specializes in developing innovative processes for producing polymers and polyurethanes using carbon dioxide and epoxides. Founded in 2011 and located in Macclesfield, the company focuses on transforming waste CO2 into valuable materials through advanced catalyst chemistry. Its product offerings include polycarbonates and polycarbonate polyols, which find applications in various sectors such as mattresses, home insulation, footwear, packaging, and construction. The company’s technology not only reduces dependence on fossil fuels but also aims to provide environmental benefits by mitigating greenhouse gas emissions. With a team of skilled scientists and engineers operating from a state-of-the-art facility at Alderley Park, Econic Technologies is committed to advancing sustainable practices in the plastics industry while fostering economic growth.

AudioScenic Limited, founded in 2017 and headquartered in Southampton, United Kingdom, specializes in developing advanced 3D audio technology that enhances the listening experience across various sectors, including cinema, gaming, production, automotive, and public spaces. The company's innovative approach utilizes small arrays of speakers combined with head-tracking technology to deliver controlled sound beams directly to the listener's ears, creating a virtual headphone effect without the need for traditional headphones or bulky speaker setups. This technology allows users to experience immersive audio that accurately simulates sound positioned in three-dimensional space, surpassing the quality of conventional loudspeaker systems. AudioScenic's solutions are adaptable for diverse applications and are supported by their proprietary Virtua 3D Engine, which is designed for efficient signal processing across various platforms. The company collaborates closely with partners and customers to provide tailored acoustic designs, ensuring an authentic and natural audio experience for all users.

Alimetry is a health technology startup located in Auckland, New Zealand, focused on creating innovative solutions for diagnosing gastrointestinal disorders. The company has developed a symptom-tracking and real-time gastric mapping monitoring device that investigates gastric function. This device detects the underlying motility of the stomach, helping to identify the causes of common symptoms such as abdominal pain, indigestion, nausea, and vomiting. By enabling patients to better understand their gastrointestinal health, Alimetry aims to enhance the overall care and management of GI disorders.

Augmented Bionics is focused on creating a non-surgical alternative to cochlear implants for individuals with severe to profound hearing loss. The company's innovative technology utilizes Transcranial Magnetic Stimulation (TMS), a safe and FDA-approved non-invasive neuromodulation method. This approach addresses the limitations of traditional hearing aids, which are often ineffective for those with significant hearing impairments. By offering a device similar to headphones that wirelessly stimulates the hearing nerve, Augmented Bionics aims to enhance accessibility for the 70 million individuals who could benefit from improved hearing, as fewer than 5% currently receive cochlear implants due to the associated surgical risks, high costs, and specialist requirements. This development seeks to deliver the advantages of cochlear implants without the barriers that accompany surgical procedures.

AccelerComm Ltd specializes in providing Forward Error Correction (FEC) solutions for various communication markets, including mobile handsets, base stations, and satellite standards. Founded in 2016 and based in Southampton, United Kingdom, the company focuses on enhancing the performance of next-generation wireless communications, addressing challenges such as noise, interference, and weak signal strength. Its product offerings include a range of encoding and decoding technologies, such as Polar, Turbo, and LDPC (Low-Density Parity-Check) decoders, specifically designed to meet 3GPP compliance. By delivering innovative semiconductor IP-core products, AccelerComm aims to facilitate optimal performance in digital communications while supporting the evolving needs of the industry.

MOBILion Systems, Inc. is a biotechnology company focused on advancing the detection and analysis of clinically relevant molecules that conventional instruments struggle to identify. The company has developed structures for lossless ion manipulation (SLIM), which facilitate ion mobility separations and enable researchers to detect minute traces of disease-specific biomolecules. Founded in 2015 and based in Chadds Ford, Pennsylvania, MOBILion's technology enhances the sensitivity, resolution, and throughput of analytical instruments. This innovation supports the identification of biologic therapeutics, accelerates biomarker discovery, and improves the accuracy of diagnostic tests. By processing large-scale samples efficiently, MOBILion aims to contribute to better disease prediction, diagnosis, and treatment, ultimately empowering clinicians and researchers to address diseases at their core rather than merely treating symptoms.

Bramble Energy Ltd. is a London-based company that specializes in the design, development, and manufacture of printed circuit board (PCB) fuel cells, specifically proton exchange membrane fuel cells (PEMFCs). Incorporated in 2015, it leverages the capabilities of the global PCB industry to produce high-performance, cost-effective fuel cell stacks. The company's product lineup includes modular PCBFC stacks, ranging from 20 W to 5 kW, as well as custom-designed solutions. Bramble Energy serves various sectors, including stationary, portable, and automotive applications, aiming to provide gigawatts of fuel cell hardware. By utilizing innovative manufacturing methods and materials, the company enables clients to reduce energy consumption and lower their carbon footprints.

MISSION Therapeutics is a biotechnology company specializing in developing drugs that target the cellular process of deubiquitylation for the treatment of cancer and other diseases. Their focus is on developing small molecule drugs that selectively inhibit specific deubiquitylating enzymes (DUBs), which play crucial roles in regulating protein degradation and cellular processes. These drugs aim to intervene in disease mechanisms where DUB dysregulation is implicated, offering potential therapeutic benefits.

Oxford Ionics is a quantum computing startup focused on advancing the development of reliable quantum computers through its innovative use of trapped-ion technology. By combining high-performance qubits with noiseless electronic qubit control, the company offers solutions that allow for precise manipulation of qubits with minimal noise. This technology supports the creation of scalable quantum chips using standard semiconductor fabrication methods, which enhances efficiency and facilitates significant progress in the quantum computing market. Clients benefit from improved computational capabilities, enabling them to tackle complex problem-solving tasks more effectively.

Navenio Limited is a software technology company based in Oxford, United Kingdom, that specializes in location-based services for indoor environments. Founded in 2015, Navenio offers a mobile application solution that enhances indoor localization by enabling the tracking of individuals without the need for additional hardware, such as beacons or Wi-Fi. This innovative approach utilizes fingerprinting of the electromagnetic spectrum, sensor data, and indoor mapping to provide accurate location monitoring across various sectors, including retail, transportation, venues, and healthcare. Navenio's intelligent workforce solution significantly improves operational efficiency and workflow by automating processes based on real-world best practices.

IBEX Innovations Limited specializes in developing and commercializing advanced X-ray detector technology that provides high sensitivity materials information using standard X-ray systems. Founded in 2010 by Dr. Gary Gibson and based in Sedgefield, United Kingdom, the company has created the IBEX multi absorption plate (MAP) technology, which enhances traditional detectors by integrating materials information while maintaining key performance characteristics like speed and spatial resolution. IBEX's solutions are utilized across various sectors, including healthcare for bone mineral density assessment, electronics inspection, food safety, and security applications. The company collaborates with academic institutions, such as the Mathematics Department at Durham University, and maintains partnerships with healthcare organizations to validate its technology in medical imaging. Supported by venture capital and grants, IBEX Innovations continues to advance its technology to transform standard X-ray imaging into powerful diagnostic tools.

Quantum Motion Technologies is focused on developing universal quantum computers utilizing silicon-based, CMOS-compatible processes. The company aims to address key challenges in quantum computing, such as fault tolerance and qubit redundancy, by creating scalable architectural technologies. By leveraging complementary metal-oxide semiconductor processing, Quantum Motion strives to achieve greater qubit density, enabling the construction of large-scale quantum systems. This approach not only enhances the performance of quantum computers but also assists clients in the quantum technology sector in overcoming significant errors and critical challenges in quantum information processing.

RFC Power Ltd, founded in 2017 and based in London, specializes in the development of low-cost hybrid flow battery systems designed for renewable energy storage. The company focuses on innovative redox flow battery chemistry that utilizes non-toxic and abundant materials, combining optimized cell architecture with hydrogen manganese chemistry. This unique approach allows RFC Power's batteries to deliver reliable energy storage with minimal capacity loss, making them suitable for various applications. By leveraging concepts from fuel cells, RFC Power aims to provide simple and safe solutions for energy storage, ensuring that renewable energy can be efficiently stored and used when needed.

Instrumems Inc. is a technology company based in Los Altos, California, specializing in the development of innovative nano-wire sensors. Founded in 2016, the company has created a sensing platform that enables the measurement of temperature, flow velocity, and humidity. These sensors are designed to be faster, more cost-effective, and smaller than traditional measuring techniques. As sensing technologies increasingly integrate into various applications, from mobile devices to aerospace, Instrumems provides high-performance, reliable, and affordable solutions suitable for multiple markets, including aerospace, automotive, engine monitoring, and natural gas. The company's technology is also well-suited for mobile applications, real-time weather monitoring, and environmental monitoring, addressing the growing demand for high-resolution and high-frequency measurements.

Mixergy Ltd, founded in 2014 and based in Cassington, United Kingdom, specializes in the development of energy storage equipment, particularly hot water tanks. The company aims to provide cost-effective solutions that enhance energy efficiency and support the integration of renewable energy sources. By optimizing the use of solar photovoltaic systems and heat pumps, Mixergy tanks contribute to grid balancing, promoting greater utilization of renewable power generation.

MOBILion Systems, Inc. is a biotechnology company focused on advancing the detection and analysis of clinically relevant molecules that conventional instruments struggle to identify. The company has developed structures for lossless ion manipulation (SLIM), which facilitate ion mobility separations and enable researchers to detect minute traces of disease-specific biomolecules. Founded in 2015 and based in Chadds Ford, Pennsylvania, MOBILion's technology enhances the sensitivity, resolution, and throughput of analytical instruments. This innovation supports the identification of biologic therapeutics, accelerates biomarker discovery, and improves the accuracy of diagnostic tests. By processing large-scale samples efficiently, MOBILion aims to contribute to better disease prediction, diagnosis, and treatment, ultimately empowering clinicians and researchers to address diseases at their core rather than merely treating symptoms.

Kira Biotech is an Australian biotechnology company focused on developing innovative immunomodulatory compounds for treating immune system disorders. The company's lead candidate, KB312, is a first-in-class monoclonal antibody designed to selectively deplete activated immune cells, aiming to restore immune balance by inducing tolerance. Kira Biotech is currently advancing KB312 through preclinical development and phase 1 clinical trials, supported by a team of experienced drug development professionals, including Dr. Dan Baker, a prominent rheumatologist and immunologist. The company has successfully secured venture capital funding to support its research and development efforts.

Inflowmatix Limited is a technology company based in London that specializes in designing and implementing electronic systems for water utilities globally. Founded in 2015 as a spin-out from Imperial College London's InfraSense Labs, Inflowmatix focuses on providing water flow and system health analytics to enhance the operation of water supply networks. Their innovative solutions continuously monitor and analyze fluid dynamics, enabling operators to optimize performance, manage leakage, and improve energy efficiency. By capturing high-frequency pressure data and applying advanced modeling techniques, Inflowmatix helps water companies gain insights into their operations, extend the life of aging infrastructure, and address challenges posed by increasing population demands and climate change. The company’s technology aims to deliver compelling returns on investment while supporting water utilities in maintaining high-quality service within cost constraints.

CareAlign offers a patient-centric task management tool that assists clinicians in tracking, managing, and coordinating clinical care. The platform provides an intuitive interface for assigning tasks with specific dates and times, categorizing them by urgency, and reviewing completed tasks. Additionally, CareAlign has developed a real-time data system that consolidates information from various sources into a cohesive and easily navigable display. This system enhances clinicians' understanding of patients' clinical statuses, ultimately improving care coordination.

Growave is an Agtech startup company offering herbicide free weed management.

WaveOptics, Ltd. is a designer and manufacturer of advanced augmented reality display technology, specializing in diffractive waveguides for wearable devices. Founded in 2014 and based in Abingdon-on-Thames, United Kingdom, the company focuses on creating optical components that enhance the augmented reality experience. Their patented technology utilizes waveguide hologram physics and photonic crystals, allowing for lightweight, high field-of-view displays in full RGB color. By employing thin transparent substrates embedded with nanostructures, WaveOptics' devices manipulate light to generate images without the need for bulkier components traditionally used in AR systems. The company has established strategic partnerships with industry leaders such as Compal, Wistron, and Plessey to further its mission in the augmented reality market.

SAM Labs Limited is an education technology company based in London that specializes in providing innovative teaching resources for educators. Founded in 2014, the company offers a range of products, including wireless electronic blocks, buttons, sensors, motors, and sliders, which can be connected and programmed using their SAM Space software application. This platform enables students to visualize and code the blocks in an intuitive manner, fostering an engaging STEAM learning experience. SAM Labs provides curriculum-based lesson plans and hands-on support for educators, making coding and computational skills accessible and interactive. Their offerings include course kits and electronic products available for purchase online, allowing educators to create a dynamic classroom environment where students can design, write, and debug their own programs, while learning essential concepts such as sequencing, selection, and logical reasoning.

Exyn Technologies, Inc. is a company focused on developing autonomous aerial robots designed for complex commercial environments. Established in 2014 as a spin-off from the GRASP Laboratory at the University of Pennsylvania, Exyn leverages over a decade of research in autonomous flight and aerial robotics. The company's flagship product, exynAI, is a modular software system that enables pilot-less flights and facilitates communication between multiple flying vehicles. Exyn's drones utilize a unique technology that integrates multiple redundant sensors, advanced mapping for obstacle avoidance, and autonomous flight planning, making them suitable for applications such as underground inspections, inventory management, and construction documentation. With their robust and highly differentiated capabilities, Exyn's aerial robots provide clients with the ability to automate dangerous tasks and address various complex operational challenges. The company is headquartered in Philadelphia, Pennsylvania.

Azuri Technologies Ltd. specializes in the development, manufacturing, and installation of solar power products aimed at off-grid communities, primarily in Africa and the United Kingdom. Founded in 2012 and headquartered in Cambridge, the company provides a variety of solar solutions, including AzuriTV, a solar-powered television, and various solar home systems that offer lighting, mobile phone charging, and other essential services. Its PayGo system allows users to access solar energy through a pay-as-you-go model, making clean energy affordable and accessible without the need for government subsidies. Azuri Technologies has established distribution networks in countries such as Kenya, Uganda, South Sudan, Zambia, and South Africa, addressing the energy access challenges faced by 1.3 billion people globally. By leveraging mobile technology, Azuri transforms energy access into a viable business, offering families a cost-effective alternative to traditional kerosene use.

IBEX Innovations Limited specializes in developing and commercializing advanced X-ray detector technology that provides high sensitivity materials information using standard X-ray systems. Founded in 2010 by Dr. Gary Gibson and based in Sedgefield, United Kingdom, the company has created the IBEX multi absorption plate (MAP) technology, which enhances traditional detectors by integrating materials information while maintaining key performance characteristics like speed and spatial resolution. IBEX's solutions are utilized across various sectors, including healthcare for bone mineral density assessment, electronics inspection, food safety, and security applications. The company collaborates with academic institutions, such as the Mathematics Department at Durham University, and maintains partnerships with healthcare organizations to validate its technology in medical imaging. Supported by venture capital and grants, IBEX Innovations continues to advance its technology to transform standard X-ray imaging into powerful diagnostic tools.

STORM Therapeutics Limited is a biotechnology company based in Cambridge, United Kingdom, focused on discovering and developing small molecule drugs that target RNA-modifying enzymes for cancer treatment and other immune diseases. Founded in 2015 and formerly known as Iceni Therapeutics Limited, the company utilizes a drug discovery and RNA analytics platform to identify novel targets and first-in-class drug candidates. By modulating RNA-modifying enzymes, STORM Therapeutics aims to address a range of diseases, including oncology, inflammation, viral infections, and central nervous system disorders. The company's innovative approach seeks to provide physicians with effective therapies targeting RNA epigenetic mechanisms.

Aqdot Limited, founded in 2012 and based in Cambridge, United Kingdom, specializes in manufacturing smart microcapsules through innovative fabrication technology. Its unique approach combines emulsion technology and supramolecular chemistry to simplify the microencapsulation process using a one-step shrink-wrap method. This technology is energy- and raw material-efficient, contributing to reduced energy consumption and waste. Aqdot's microcapsules have versatile applications across various industries, including home care, beauty, pet care, food, and agrochemicals. The encapsulation technology enables the protection and controlled release of active ingredients, making it suitable for products like laundry detergents, fertilizers, and odor-capturing technologies. With a focus on customization, Aqdot serves a multi-billion-dollar market, addressing the growing demand for effective and sustainable encapsulation solutions.

Inivata Limited is a clinical cancer genomics company based in Cambridge, United Kingdom, established in 2014. The company specializes in the analysis of circulating tumor DNA (ctDNA) to enhance cancer testing and treatment for oncologists and their patients. Inivata's innovative approach utilizes TAm-Seq technology to detect and analyze genomic material from a patient's cell-free ctDNA, collected through non-invasive blood samples, known as liquid biopsies. This method revolutionizes cancer detection and monitoring by providing a less invasive alternative to traditional biopsies. The company's focus is on enabling clinicians to make more informed treatment decisions by monitoring response to therapies and detecting potential relapses in cancer patients. Inivata has also formed a strategic collaboration with NeoGenomics, Inc.

AccelerComm Ltd specializes in providing Forward Error Correction (FEC) solutions for various communication markets, including mobile handsets, base stations, and satellite standards. Founded in 2016 and based in Southampton, United Kingdom, the company focuses on enhancing the performance of next-generation wireless communications, addressing challenges such as noise, interference, and weak signal strength. Its product offerings include a range of encoding and decoding technologies, such as Polar, Turbo, and LDPC (Low-Density Parity-Check) decoders, specifically designed to meet 3GPP compliance. By delivering innovative semiconductor IP-core products, AccelerComm aims to facilitate optimal performance in digital communications while supporting the evolving needs of the industry.

C-Capture Limited, founded in 2008 and based in Leeds, United Kingdom, specializes in the development and design of solvent systems for the removal of carbon dioxide (CO2) from gas streams. The company utilizes its expertise in CO2-based chemistry and engineering to create absorbents for reversible CO2 capture, particularly in post-combustion processes. C-Capture focuses on providing non-toxic and economically viable carbon capture solutions for emission sources, including flue gases from power generators and hard-to-abate industries. By offering innovative technology for capturing CO2, C-Capture aims to contribute to more sustainable electricity generation and address the environmental challenges posed by greenhouse gas emissions.

Istesso is a biotechnology company focused on drug discovery and development within the field of immunometabolism. Founded in 2017, it serves as the holding company for Modern Biosciences Ltd. The company specializes in creating therapies aimed at reprogramming metabolism to address autoimmune and inflammatory diseases, particularly rheumatoid arthritis and multiple sclerosis. Istesso's pipeline includes both pre-clinical and clinical assets designed to provide disease-resolving solutions for chronic conditions, enhancing the ability of healthcare professionals to effectively diagnose and treat these disorders.

Featurespace is a leader in enterprise financial crime prevention, specializing in fraud detection and anti-money laundering solutions. The company has developed innovative technologies, including Adaptive Behavioral Analytics and Automated Deep Behavioral Networks, which are incorporated into its ARIC platform. This real-time machine learning software assesses risk and monitors customer data across more than 180 countries to identify fraudulent activities and suspicious behavior promptly. The ARIC Risk Hub utilizes advanced anomaly detection methods, allowing financial institutions to automatically recognize potential threats and respond to them effectively. Over 30 major global financial institutions, including well-known names such as HSBC and NatWest, leverage Featurespace’s solutions to safeguard their operations and enhance customer satisfaction while minimizing fraud-related costs.

AudioScenic Limited, founded in 2017 and headquartered in Southampton, United Kingdom, specializes in developing advanced 3D audio technology that enhances the listening experience across various sectors, including cinema, gaming, production, automotive, and public spaces. The company's innovative approach utilizes small arrays of speakers combined with head-tracking technology to deliver controlled sound beams directly to the listener's ears, creating a virtual headphone effect without the need for traditional headphones or bulky speaker setups. This technology allows users to experience immersive audio that accurately simulates sound positioned in three-dimensional space, surpassing the quality of conventional loudspeaker systems. AudioScenic's solutions are adaptable for diverse applications and are supported by their proprietary Virtua 3D Engine, which is designed for efficient signal processing across various platforms. The company collaborates closely with partners and customers to provide tailored acoustic designs, ensuring an authentic and natural audio experience for all users.

Import.io Ltd is a London-based company that specializes in web data integration, providing a software-as-a-service (SaaS) platform designed to convert unstructured web data into structured, machine-readable formats. Founded in 2012, Import.io offers a suite of products including Import.io Extract for automated web extraction, Import.io Insights for data monitoring and visualization, and Import.io API for seamless integration with various systems and workflows. The platform enables users to efficiently gather and analyze data from millions of web sources, supporting applications such as competitor price monitoring, MAP compliance, product matching, and customer sentiment analysis. With a diverse client base of over 850 customers, Import.io delivers comprehensive web data solutions that fuel business insights and competitive advantages across various industries.

WaveOptics, Ltd. is a designer and manufacturer of advanced augmented reality display technology, specializing in diffractive waveguides for wearable devices. Founded in 2014 and based in Abingdon-on-Thames, United Kingdom, the company focuses on creating optical components that enhance the augmented reality experience. Their patented technology utilizes waveguide hologram physics and photonic crystals, allowing for lightweight, high field-of-view displays in full RGB color. By employing thin transparent substrates embedded with nanostructures, WaveOptics' devices manipulate light to generate images without the need for bulkier components traditionally used in AR systems. The company has established strategic partnerships with industry leaders such as Compal, Wistron, and Plessey to further its mission in the augmented reality market.